Changing Life Sciences Value Chain

Archives for April 2009 « Recent Articles

Photo of Dr. Alan S. LouieOffline

Information regarding the current spread of the swine flu is available from a wide range of sources and is often being perpetuated with little regard for purpose or facts.  With near real-time sharing through sources like Twitter (Search term: #swineflu), regular updates from trusted health sources like the World Health Organization ( and the CDC (, traditional TV and radio, e-mail, and the internet, we are bombarded by information about the swine flu

Photo of Eric NewmarkOffline

RFID Adoption Goes Flat

By Eric Newmark

RFID adoption in the life sciences has been steadily increasing over the past 3 years. While growth has been much slower than the adoption curve many had predicted for the technology back in the late 1990's, testing and evaluation of RFID had been increasing at a steady pace. However, it now appears that this momentum has ceased, and adoption has gone flat. <!-- /* Font Definitions */@font-face\t{font-family:Wingdings;\tpanose-1:5 0 0 0 0 0 0 0 0 0;\tmso-font-charset:2;\tmso-generic-font-fami

Photo of Dr. Alan S. LouieOffline

Building a Future Based on Biotech: The Safe Bet?

By Dr. Alan S. Louie

During these financially lean times, both life science companies and government entities are taking one of two paths with regards to allocation of limited resources.  In the first case, organizations are cutting back, tightly restricting spending that doesn't have a near-term ROI, and deferring long term decision making to the future.  Alternatively organizations are allocating some of their coveted resources based on the assumption that biotechnology holds the promise for the future and that inve

Photo of Eric NewmarkOffline

We recently launched a second study focusing on revenue leakage in the life sciences. While our first study on this topic, conduct in 2007, helped quantify revenue leakage for the industry and presented some eye-opening results (pharmas lose 4.5% of revenue annually), the study was largely based on data from manufacturers. The current line of research will not only provide updated figures to the prior findings, but will specifically seek out data and perspective from both wholesalers and group purchasing or

Photo of Dr. Alan S. LouieOffline

It is clear to all that improved access to information both across the organization and from the public domain would better empower innovative thinking, reduce risk in decision making (both scientific and business), and accelerate drug development.  Despite this generally agreed-to goal, data silos abound within life science organizations, resulting in uninformed decision making and wasted efforts.  Corporate initiatives look to universally convert paper to eNotebooks, connect databases within org

Viewed 763,123 times